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Background: Ebosin is a novel exopolysaccharide (EPS) produced by Streptomyces sp. 139 and evidenced to
possess an anti-rheumatic arthritis activity in vivo. The Ebosin biosynthesis gene cluster (ste) consists of 27 ORFs and
ste7 has previously been demonstrated to code for a fucosyltransferase, which plays an essential role in the formation
of repeating sugar units during Ebosin production. Aiming to generate derivatives of Ebosin for better activity, we
replaced ste7 with a gene encoding for a glucosyltransferase (gtf) from Streptococcus thermophilus.
Results: This alteration resulted in a novel Ebosin derivative (EPS-7 g) with its monosaccharide composition
dramatically changed, especially in the proportion of glucose which increased from 1.1% (Ebosin) to 84.01%
(EPS-7 g). In an ELISA analysis, EPS-7 g exhibited a higher binding activity for IL-1R, as a competitor of interleukin-1, than
that of Ebosin. It also exhibited a higher inhibitory effect on the activity of IL-1β-converting enzyme and production of
IL-1β in fibroblast-like synoviocytes (FLS). In addition, experiments with acute inflamed mice induced by croton oil
showed a significantly higher anti-inflammatory activity of EPS-7 g compared with Ebosin.
Conclusions: The new Ebosin derivative EPS-7 g is more bioactive than Ebosin evaluated by a series of experiments.
This is the first report demonstrating a modification of EPS structure via heterologous gene replacement in Streptomyces.
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One type of microbial polysaccharides are secreted out
of the cells [1] and therefore called exopolysaccharides
(EPSs), which are long-chain polysaccharides consisting
of branched, repeating units of sugars or sugar deriva-
tives [2]. In bacteria, EPS biosynthesis starts with the
intracellular formation of EPS precursors and the sugar
nucleotides, followed by the formation of a repeating
unit on a lipid carrier which is located in the cytoplas-
mic membrane. The later steps involve transport of the
repeating units across the membrane to the outer layer* Correspondence: yuanwli@263.net
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unless otherwise stated.and polymerization of tens and even hundreds of such
units to form the final EPSs [3]. During the process, gly-
cosyltransferases play important roles to sequentially
transfer sugars from intracellular nucleotide sugars to a
lipid carrier acceptor [4].
In order to improve applications of EPSs, genetic en-
gineering can be used in the production of desired poly-
saccharides targeting predefined macroscopic properties.
Based on the available genetic information, genetic
modification of eps genes should lead to EPSs with a
different repeating unit or with a different chain length
[5]. Manipulation of genes which function in export,
polymerization, and determination of chain length during
EPS biosynthesis were also proved effective for altering
EPS structure [6]. Heterologous production of an EPS has
been successful by transfer of the complete eps gene clus-
ter alone of a LAB strain into a non EPS-producingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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possessed all necessary genetic information for precursor
synthesis [7]. Ingeborg et al [8] described increased exopo-
lysaccharide production in Lactoccus lactis due to manip-
ulated overexpression of the NIZO B40 eps gene cluster,
the first report demonstrating that homologous overex-
pression of a complete eps gene cluster in Lactoccus lactis
leads to increased EPS production.
Streptomyces are a group of gram-positive bacteria that
have been intensively studied for their secondary metab-
olites, particularly antibiotics. However, little is known of
the production of EPSs in Streptomyces. Recently a novel
EPS namely Ebosin was isolated from the supernatants of
fermentation cultures of Streptomyces sp. 139 [9], which
has remarkable anti-rheumatic arthritis activity in vivo
[10]. Its biosynthesis gene cluster (ste) consisting of 27
ORFs was also identified [11]. Efforts have been made in
elucidating the function of individual ste genes [12-15]. In-
sights into the biosynthesis pathways of polysaccharides
are crucial for the exploitation of microorganisms to pro-
duce polysaccharides of industrial or medicinal import-
ance. With a number of the ste genes identified, it is now
possible to carry out specific manipulations for creating
Ebosin derivatives which can then be screened for better
bioactivities. This paper reports our endeavor to generate
such derivatives by tackling the ste7 gene encoding a fuco-
syltransferase, which catalyzes the transfer of fucose spe-
cifically from GDP-fucose to a fucose acceptor during
Ebosin biosynthesis [16]. In this study, we replaced ste7
with the glucosyltransferase gene (gtf) from Streptococcus
thermophilus, which is a gram-positive bacterium and
most valuably used in food industry. Stingele et al [17]
identified the eps genetic locus of S. thermophilus Sfi6, re-
vealing a 15.25-kb region containing 16 open reading
frames (ORFs), within a 14.52-kb region encodes 13 genes
(epsA to epsM) capable of directing EPS synthesis. The
resultant EPS-7 g produced by the strain Streptomyces
sp. 139 (gtf ) has a very high content of glucose and exhib-
ited remarkably higher bioactivities than that of Ebosin in
both in vitro and in vivo assays.
Results
Construction of the heterologous gene replacement
strain Streptomyces sp. 139 (gtf)
The replacement of ste7 gene by the gtf gene of S. ther-
mophilus (Figure 1A) was evidenced by Southern hybridization
using a 1.03-kb DNA (F1) as probe upstream of ste7
(Figure 1B). The hybridization signals appeared with the
expected sizes of 4.0 kb for Streptomyces sp. 139 (gtf) and
3.1 kb for Streptomyces sp. 139 (ste7-). This result indicated
that the colonies with thior Ams phenotypes had integrated
the gtf-thior cassette into the kanamycin resistance gene,
therefore, confirmed the establishment of heterologous
gene replacement strain Streptomyces sp. 139 (gtf).Sugar composition of EPSs
GC analysis of Ebosin, EPS-7 m produced by the knock
mutant Streptomyces sp. 139 (ste7-) and EPS-7 g by Strep-
tomyces sp. 139 (gtf) (Figure 2A, B, C) showed that these
EPSs consisted of the same monosaccharides: glucose,
mannose, arabinose, galactose, fucose, xylose and rham-
nose, of which the most striking was an increase of glu-
cose proportion from 1.1% (Ebosin) to 84.01% (EPS-7 g).
While, some proportional changes of other sugars also oc-
curred in comparison with Ebosin (Figure 2D). Using a
method based on uronic acid carbazole reaction, galac-
turonic acid was also found in EPS-7 m and EPS-7 g.
The competitive binding activity of Ebosin derivates with
IL-1 for IL-1R
Using an ELISA assay, the competitive binding activities
of Ebosin, EPS-7 m and EPS-7 g with IL-1 for IL-1R
were determined.
For EPS-7 m they were 6.1% and nil (P < 0.05) at dos-
ages of 0.64 ng/μL and 0.128 ng/μL respectively, which
were remarkably lower than those of Ebosin (24.2%,
13.7%) at the same dosages. Higher binding activities of
EPS-7 g were detected to be 27.1% and 24.3% (P < 0.05)
respectively compared with that of Ebosin at same con-
centrations (Figure 3).
Effect of Ebosin derivates on the enzymatic activity for
IL-1β-converting enzyme (ICE)
At concentrations of 0.64 ng/μL and 0.128 ng/μL, Ebosin
suppressed the enzyme with inhibition ratios 35.5% and
25.0% respectively, compared with 15.5% (P < 0.05), 14.3%
for EPS-7 m and 47.6%, 35.7% (P < 0.05) for EPS-7 g re-
spectively (Figure 4A). The results demonstrated a higher
activity of EPS-7 g to inhibit the IL-1β-converting enzyme.
Inhibiting effect of Ebosin derivates on production of
IL-1β in FLS cells
To assess the effects of Ebosin, EPS-7 m and EPS-7 g on
production of IL-1β in FLS (fibroblast-like synoviocytes),
cell cultures were carried out and stimulated with LPS at
37°C for 72 h before analyzed by ELISA. The results
indicated (Figure 4B) that Ebosin, EPS-7 m and EPS-7 g
at dosage of 3.2 ng/μL reduced the IL-1β production
52.03% (P < 0.01), 26.17%, 58.70% (P < 0.01) respectively
and 45.57% (P < 0.5), 15.39%, 52.34% (P < 0.01) at dosage
of 0.64 ng/μL separately. With dosage of 0.128 ng/μL,
the IL-1β production were suppressed 31.61%, 10.16%
and 47.82% (P < 0.01) individually.
Effect of Ebosin and EPS-7 g on the inflammatory activity
in the acute inflamed mice induced by croton oil
To evaluate the effect of Ebosin and EPS-7 g on the acute
inflamed mice induced by croton oil, the mice were ran-
domly divided into three groups described as above. Ebosin
Figure 1 The diagram of gene replacement and Southern blot analysis. (A) Diagram of gene replacement of ste7 with gtf originated
from Streptococcus thermophilus through a double crossover via homologous recombination. Gray box indicates the location of Kmr gene
in Streptomyces sp. 139 (ste7-). Restriction maps of Streptomyces sp. 139 (ste7-) and the gene replacement strain Streptomyces sp. 139 (gtf) show the
predicted fragment sizes upon BamHI digestion. (B) Southern blot autoradiograph of Streptomyces sp. 139 (ste7-) and Streptomyces sp. 139 (gtf).
1. Chromosome DNA of Streptomyces sp. 139 (ste7-) digested with BamHI; 2. chromosome DNA of Streptomyces sp. 139 (gtf) digested with BamHI.
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each mouse of the respective experimental groups for
1 h before induction by croton oil. Compared with the
acute inflamed mice groups untreated (control), the inhib-
ition ratios of EPS-7 g and Ebosin for mice ear edema
were 48.61% (P < 0.05) and 21.60% respectively (Figure 5),
indicating that EPS-7 g surpasses Ebosin by over 100% onFigure 2 GC chromatograms of sugar analysis of Ebosin (A), EPS-7 m
5. mannose, 6. glucose, 7. galactose. (D). Monosaccharide compositions of
method based on uronic acid carbazole reaction (Bitter et al., 1962).suppressing the inflammatory activity in the acute in-
flamed mice.
Discussion
Exopolysaccharides include a range of diverse polymers
that play vital roles in variety of biological processes. In
addition, EPSs have also significant industrial applications,(B) and EPS-7 g (C). 1. rhamnose, 2. fucose, 3. arabinose, 4. xylose,
Ebosin, EPS-7 m and EPS-7 g. Galacturonic acid was analyzed using a
Figure 5 Effect of EPSs on inflammatory activity in the acute
inflamed mice induced by croton oil.
Figure 3 Binding activities of Ebosin, EPS-7 m and EPS-7 g to
IL-1R determined by an ELISA assay.
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EPSs produced by lactic acid bacteria contribute signifi-
cantly to the structure and viscosity of fermented milk
products [18]. The health value of these macromolecules
has also emerged in recent years; many reports indi-
cate that they can confer health benefits on consumers
arising from their immunogenic and cholesterol-lowering
properties [19,20]. EPSs produced by Trichoderma eri-
naceum DG-312 was shown to have a strong anti-
inflammatory activity in inflamed mice [21]. Enterobacter
cloacae was also found to produce EPSs with anti-diabetic
activity [22].Figure 4 Suppression of ICE enzymatic activity (A) and inhibited
production of IL-1β in FLS (B) by Ebosin, EPS-7 m and EPS-7 g.
*, P < 0.05; **, P < 0.01; ***, P < 0.001 versus FLS without stimulating
with LPS (control 1).Metabolic engineering has enabled generation of “de-
signer” polysaccharides in lactic acid bacteria (LAB), which
mostly involved manipulations of glycosyltransferases [2].
Introducing new or existing glycosyltransferases into LAB
[4] or gene shuffling with glycosyltransferases are effective
means for controlling EPS structure [5]. Masja et al [23] re-
ported that heterologous production of the pneumococ-
cal serotype 14 polysaccharide in Lactococcus lactis
resulted in the recombinant product secreted into culture
medium, which simplified downstream processing. This
was achieved by coexpressing the pneumococcal gene
cluster cpsFGHIJKL14 with the lactococcal regulatory and
priming glucosyltransferase-encoding genes (epsABCDB40)
specific for B40 polysaccharide. Knoshaug et al [24] re-
ported evidence for a novel gene organization expressing
EPS in Lactococcus lactis subsp. cremoris Ropy352 and
showed the specificities of polymerization and export en-
zymes blocking the function of just one glycosyltransferase
abolished the production of ropy EPS. Heterologous ex-
pression of glycosyltransferases has been found to result
in different sugars added at strategic positions in generat-
ing EPSs with new properties [5].
Ebosin is a novel EPS with anti-rheumatic arthritis ac-
tivity. It has been shown that Ebosin is an inhibitor of
IL-1β-converting enzyme (ICE), a key enzyme in synthe-
sis of IL-1β [25]. More recently, evidence has also been
obtained demonstrating that the anti-inflammatory effect
of Ebosin on rat collagen-induced arthritis is through sup-
pressing production of interleukin-1β, interleukin-6 and
tumor necrosis factor α at both transcriptional and post-
translational levels [10]. This EPS is therefore of medicinal
value so improvement for better property is warranted. In
this study, a glucosyltransferase gtf gene from S. thermo-
philes was expressed in replacement of the ste7 gene which
encodes a fucosyltransferase in the Ebosin-producing strain
Streptomyces sp. 139. This brought about dramatic changes
in the property of EPS produced. Because of the complexity
of the biosynthesis pathway of Ebosin and involvement of a
large number of genes, once ste7 was replaced with the
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the increased incorporation of glucose, but also on the
overall sugar profile. The reason for these changes, which
are apparently not a simple proportional change of com-
position with increased glucose, may lie in the primary
structure. The resultant EPS-7 g turns out to be more bio-
active compared with Ebosin evaluated by its ICE inhibi-
tory activity, suppression of interleukin-1β production
in fibroblast-like synoviocytes (FLS), competitive binding
to IL-1R against IL-1 and suppression of the acute inflam-
matory activity in the acute inflamed mice induced by
croton oil. According to these results, it looks like that in-
creasing proportion of glucose effects on bioactivity of
EPS-7 g. A good understanding of the correlation between
structure and bioactivity of Ebosin is important because it
will provide a foundation for a strategy aimed at producing
functionally more valuable polysaccharides. Continuing ef-
forts in the elucidation of Ebosin biosynthesis pathway will
enable more rational designs for genetic manipulation to
generate highly effective derivatives.
Conclusions
EPS-7 g, a novel Ebosin derivate, was produced by heter-
ologous gene replacement in Streptomyces sp. 139, which
was more bioactive compared with Ebosin evaluated by
a series of experiments. To our knowledge, this is the
first report on manipulation of EPS structure by introdu-
cing heterologous glucosyltransferases into Streptomyces.
Methods
Bacterial strains and culture conditions
Streptomyces sp. 139 was isolated from a soil sample in
China and kept in the China General Microbiology Culture
Collection Center (No. 0405) (Table 1). Streptomyces sp.Table 1 Bacterial strains and plasmids used in this study
Strain or plasmid Description
Strains
E.coli DH5α supE44 Δ lacU169 (φ80 lacZ ΔM
E. coli DH5a (pUC-gtf) E. coli DH5a clone with gtf
E. coli ET12567 Methylation-deficient E. coli dam
Streptomyces sp. 139 Ebosin producing strain
Streptomyces sp. 139 (ste7-) The gene ste7 disruption mutan
Streptomyces sp. 139 (gtf) Ams, thior, the heterologous gen
Streptococcus thermophilus Wild type
Plasmids
pUC18 Ampr, E.coli general cloning vect
pUC-gtf Ampr, pUC18 derived plasmid ca
pKC7 Kmr, Amr, pKC1139 derived plasm
pKC7-gtf pKC7 carrying gtf gene
pEGM-T-tsr pEGM-T carrying thior gene139 (ste7-) was generated previously [16] and kept in our
laboratory. These strains were cultured at 28°C with shak-
ing (250 rpm) in either TSB medium supplemented with
5 mM MgCI2 and 0.5% glycine or fermentation medium
(1% glucose, 2% starch, 2% soybean extract, 0.2% tryptone,
0.2% beef extract, 0.4% yeast extract, 0.05% K2HPO4, 0.3%
CaCO3, pH 7.3). Streptococcus thermophilus was obtained
from China Industrial Microbiology Culture Collection
Center (CICC 20370) (Table 1)and cultured in LB medium
at 40°C.
Animal
Kunmin mice (male, 18-20 g, Certificate No. SCXK
2005-0013) and Wistar rats (male, 180 ± 20 g, Certificate
No.: SCXK 2005-0013) were purchased from the Institute
of Experimental Animals, Chinese Academy of Medical
Sciences, Beijing. All rats were housed under standard
laboratory conditions with the approval of the Institute
of Experimental Animals and Use Committee of Chinese
Academy of Medical Sciences.
Cell culture of FLS (fibroblast-like synoviocytes)
Synovial tissues obtained from the knee joints of sacri-
ficed CIA (collagen- induced arthritis) rats [26] on day
30 after immunization were minced and digested with
type II collagenase (0.4%, Gibco) at 37°C in a humidified
5% CO2 incubator for 2 h in Dulbecco’s modified Eagle’s
medium (DMEM), thoroughly washed and then cultured
in DMEM supplemented with fetal bovine serum (15%,
Gibco). At confluence, adherent cells were trypsinized
(0.25%, Hyclone) at 37°C for 0.5 h, filtered and exten-
sively washed again. The adherent cells were cultured in
DMEM containing fetal bovine serum, 100 units/mL
penicillin and 100 μg/mL streptomycin in a humidifiedReference





e replacement strain of Streptomyces sp.139 This study
CICC 20370
or with multiple cloning site [27]
rrying gtf gene This study
id carrying F1, F2 This study
This study
Lab stock
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passage 3-4 were seeded at 1 × 106/mL in 24-well plates
(Nunc) or at 1 × 105/mL in 6-well plates in DMEM and
cultivated at 37°C for 24 h.
DNA isolation and southern blot analysis
Isolation of E. coli plasmid DNA, S. thermophilus gen-
omic DNA and standard recombinant DNA techniques
were performed as described by Sambrook and Russell
[27]. Streptomyces plasmid and genomic DNA was iso-
lated as mentioned by Kieser et al [28]. For Southern
blot analysis, the DIG high prime DNA labeling and de-
tection starter kit II obtained from Roche (USA) was
used following the instructions of manufacturer.
Cloning of the gene gtf of Streptococcus thermophilus
The genomic DNA isolated from 48-hour cultured S.
thermophilus was used as template. The gtf gene was
amplified by PCR using primers P1 and P2 (Table 2) in
the following conditions: an initial denaturation at 94°C
for 10 min; 30 cycles of 1 min at 94°C, 1 min at 47°C
and 3 min at 72°C; and finally 10 min at 72°C. The amp-
lified DNA fragment was cloned into plasmid pUC18
digested with EcoRI and SalI to construct pUC-gtf . The
correct nucleotide sequence of gtf gene fragment cloned
in pUC-gtf was verified by sequencing using an ABI
PRISM 377XL DNA Sequencer (Applied Biosystems).
Then the recombinant plasmid pUC-gtf was transformed
into the strain E. coli DH5α to produce the strain E. coli
DH5α (pUC-gtf ). This plasmid pUC-gtf was isolated ac-
cording the protocol mentioned by Sambrook and Rus-
sell [27].
Construction of the strain Streptomyces sp. 139 (gtf)
With the plasmid pEGM-T-tsr (unpublished data) as
template, the thiostrepton resistant gene (thior) was
amplified by PCR using primers P3 and P4 (Table 2) in
the following conditions: an initial denaturation at 94°C
for 5 min; 30 cycles of 1 min at 94°C, 0.5 min at 58°C
and 2 min at 72°C; and finally 10 min at 72°C. The amp-
lified 1.06 kb gene fragment (thior) was inserted into
plasmid pUC-gtf digested with SalI- HindIII , which was
then digested by XbaI to isolate the fragment of thior-gtf.
During construction of the ste7 gene disrupted strain
Streptomyces sp. 139 (ste7-) in previous study [16], the
gene ste7 disruption vector pKC7 containing a 1.03-kb F1Table 2 Oligonucleotide primers used in this study




P4 5′-GCAAGCTT TCTAGATGATCATCACTGACGAAT-3′fragment upstream of the gene ste7 and a F2 0.899-kb
fragment downstream of the gene ste7 was created. The
fragment of thior-gtf was introduced into the ste7 dis-
ruption vector pKC7 at XbaI site to construct the
gene replacement plasmid pKC7-gtf. Propagated in
the methylation-deficient E. coli 12567 [29], pKC7-gtf
was isolated and introduced into Streptomyces sp. 139
(ste7-) by polyethylene glycol (PEG)-mediated proto-
plast transformation [28]. Incubated at 28°C for 16 to
20 h, the plates were overlaid with soft R2YE (0.7%
agar) containing apramycin (40 μg/mL). Plasmid pKC7-
gtf bears a temperature-sensitive Streptomyces replication
origin [20] that is unable to replicate at temperatures
above 34°C. Therefore, the transformants were first incu-
bated at 28°C for 2 days until pinpoint size colonies became
visible and then shifted to 37°C for further incubation.
Strains resulted from a double crossover via homologous
recombination grew out of the original pinpoint-size col-
onies in several days. The heterologous gene replacement
strain Streptomyces sp. 139 (gtf) was selected by both apra-
mycin sensitivity (Ams, 40 μg/mL) and thiostrepton resist-
ance (thior, 50 μg/mL).
Five thior Ams colonies were selected randomly and the
isolated genomic DNA originated from Streptomyces sp.
139 (gtf) and Streptomyces sp. 139 (ste7-) [16] were digested
with BamHI individually before DNA blot analysis.
Isolation of EPSs
The strains of Streptomyces sp. 139, Streptomyces sp. 139
(ste7-) and Streptomyces sp. 139 (gtf ) were cultured at
28°C for 96 h respectively. Following the protocol as de-
scribed before [9], Ebosin, EPS-7 m and EPS-7 g were
isolated from the supernatants of fermentation cultures
of respective strains.
Monosaccharide analysis of EPSs
Sugar composition analysis was performed as described
by Sun et al [30]. The purified polysaccharide samples
(10 mg) was dissolved in 3 ml of 2 M TFA to hydrolyze
at 115°C for 3 h, then drying under a stream of nitrogen.
Subsequently, the residue was treated with 200 μL of
0.5 M Na2CO3 at 30°C for 45 min and added 1.5 mL of
4% NaBH4 at room temperature for 2 h. After that, the
sample was neutralized with 25% acetic acid and loaded
onto a cation exchange resin column eluted with H2O,
then discharged the excess NaBH4 with methanol. The
sample residue was dried with P2O5 in vacuum at 85°C
for 2 h and acetylated with 2.5 mL of acetic anhydride in
0.5 mL of pyridine at 100°C for 30 min. After cooling,
the excess reagent was discharged under a stream of ni-
trogen and the sample was analyzed by Gas Chromatog-
raphy (GC, HP5890, HEWLETT, Houston, TX, USA).
Galacturonic acid was analyzed using a method based
on uronic acid carbazole reaction [31].
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The enzyme-linked immune specific assay (ELISA) method
reported previously was used to analyze the binding activ-
ity for IL-1R of isolated EPSs [15].Assay of the enzymatic activity for IL-1β-converting
enzyme (ICE)
We found recently that Ebosin is an inhibitor of IL-1β-
converting enzyme [32], a key enzyme in synthesis of IL-
1β. To assess the inhibitory effects of EPS-7 m [16] and
EPS-7 g on ICE enzymatic activity, the assay was con-
ducted according to the protocol reported by koizumi et
al [33]. The enzymatic reactions were performed in
100 μL reaction solution consisting of 20 mM HEPES
(pH 7.5), 0.1 mM NaCl, 5 mM dithiothreitol, 10% sucrose,
250 μM substrate N-acetyl-Tyr-Val-Ala-Asp- p-nitroani-
lide, 2.0 IU of IL-1β-converting enzyme (ICE), 0.64 ng/μL
and 0.128 ng/μL of Ebosin, EPS-7 m and EPS-7 g respect-
ively at 37°C for 45 min.Enzyme-linked immunosorbent assays of IL-1β in FLS cells
FLS was seeded at 1 × 106/mL in 24-well plates and cul-
tivated at 37°C for 24 h. Ebosin (3.2-0.128 ng/μL) was
added individually to each well and cultivated at 37°C
for 1 h, then FLS were stimulated with LPS (5 μg/mL
per well) at 37°C for 72 h. IL-1β in the supernatants
were analyzed with ELISA kits (Applygen). The culti-
vated FLS cells un-stimulated with LPS were as contro1,
while the cultivated FLS cells stimulated with LPS but
not treated by Ebosin were as control 2.Treatment of the acute inflamed mice induced by croton
oil
The mice were randomly divided into three groups:
acute inflammatory mice [34], Ebosin + acute inflamma-
tory mice and EPS-7 g + acute inflammatory mice (n = 8
in each group). Ebosin and EPS-7 g (100 mg/kg) were or-
ally administered to each mouse in the treatment groups.
After 1 h, 50 μL of 2% croton oil (in absolute ethyl alco-
hol) was smeared on the left auricle of each mouse in
three groups for 4 h. All the mice were then sacrificed and
ears were excised. The degree of ear edema was measured
by weighing deference between the right and left ear.Statistical analysis
Data were presented as the mean ± SD from at least 3 in-
dependent experiments. The significance of differences
between groups was evaluated by Student’s t-test. p values
less than 0.05 were considered significant.
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